Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II stratified study of cetuximab in recurrent glioblastoma multiforme
2005-000459-14Phase 2Active
- Sponsor
- Oncologisch Centrum Amsterdam
- Start
- Jul 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of cetuximab in glioblastoma (GBM) (2 arms), sponsored by Oncologisch Centrum Amsterdam. Primary endpoint: Objective tumor response. Started Jul 2007; status: active.
02
Drugs
cetuximab
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2005-000459-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000459-14.